Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,388 | 639 | 99.8% |
| Education | $18.62 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,091 | 77 | $0 (2024) |
| ABBVIE INC. | $794.68 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $717.44 | 24 | $0 (2023) |
| GlaxoSmithKline, LLC. | $660.13 | 38 | $0 (2024) |
| Lilly USA, LLC | $616.00 | 45 | $0 (2024) |
| PFIZER INC. | $613.02 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $608.26 | 37 | $0 (2024) |
| Amgen Inc. | $561.25 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $536.25 | 31 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $367.54 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,851 | 110 | PFIZER INC. ($283.17) |
| 2023 | $2,024 | 128 | Novo Nordisk Inc ($214.55) |
| 2022 | $1,816 | 119 | Novo Nordisk Inc ($208.04) |
| 2021 | $1,834 | 128 | Novo Nordisk Inc ($283.90) |
| 2020 | $441.26 | 29 | Novo Nordisk Inc ($60.69) |
| 2019 | $785.12 | 53 | Janssen Pharmaceuticals, Inc ($155.46) |
| 2018 | $1,089 | 54 | Janssen Pharmaceuticals, Inc ($356.36) |
| 2017 | $567.39 | 21 | GlaxoSmithKline, LLC. ($162.87) |
All Payment Transactions
642 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: VACCINES | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Obesity | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.97 | General |
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardio-renal | ||||||
| 09/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Bone Health | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 930 | 1,780 | $305,621 | $122,710 |
| 2022 | 13 | 689 | 1,134 | $190,801 | $77,257 |
| 2021 | 9 | 548 | 939 | $131,060 | $52,990 |
| 2020 | 16 | 559 | 697 | $92,205 | $34,981 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 736 | $155,622 | $57,359 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 163 | 163 | $36,263 | $19,610 | 54.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 75 | 295 | $30,090 | $13,694 | 45.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $13,240 | $5,624 | 42.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 36 | 36 | $11,808 | $5,428 | 46.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 65 | $12,025 | $4,655 | 38.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 25 | 97 | $13,871 | $3,459 | 24.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $5,680 | $2,424 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 49 | $7,104 | $2,400 | 33.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 67 | $2,345 | $1,938 | 82.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,520 | $1,709 | 48.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 45 | $5,040 | $1,623 | 32.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 33 | $3,795 | $1,166 | 30.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 65 | $2,860 | $618.80 | 21.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $888.00 | $578.60 | 65.2% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 25 | 25 | $1,100 | $341.75 | 31.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 37 | $370.00 | $81.40 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 628 | $131,252 | $50,299 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $12,818 | $7,308 | 57.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $11,916 | $5,019 | 42.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 57 | 58 | $7,500 | $3,969 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 35 | $5,040 | $2,118 | 42.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 14 | $4,970 | $1,948 | 39.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $3,608 | $1,779 | 49.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 64 | $2,245 | $1,760 | 78.4% |
About Dr. Casey Hurst, MD
Dr. Casey Hurst, MD is a General Practice healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1588892814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Casey Hurst, MD has received a total of $10,407 in payments from pharmaceutical and medical device companies, with $1,851 received in 2024. These payments were reported across 642 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($10,388).
As a Medicare-enrolled provider, Hurst has provided services to 2,726 Medicare beneficiaries, totaling 4,550 services with total Medicare billing of $287,938. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties Family Medicine
- Location Greenville, SC
- Active Since 06/25/2009
- Last Updated 06/24/2021
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1588892814
Products in Payments
- Ozempic (Drug) $563.89
- JARDIANCE (Drug) $513.59
- Kerendia (Drug) $367.54
- MOUNJARO (Drug) $363.77
- INVOKANA (Drug) $357.16
- XIFAXAN (Drug) $341.96
- FARXIGA (Drug) $331.52
- ELIQUIS (Drug) $316.71
- XARELTO (Drug) $309.84
- TRELEGY ELLIPTA (Drug) $303.01
- VRAYLAR (Drug) $283.79
- Dexcom G6 Transmitter (Medical Supply) $280.57
- Aimovig (Biological) $255.89
- UBRELVY (Drug) $241.49
- NURTEC ODT (Drug) $232.92
- TRADJENTA (Drug) $192.86
- AFREZZA (Drug) $161.87
- Rybelsus (Drug) $152.96
- QULIPTA (Drug) $151.17
- EVENITY (Biological) $143.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Greenville
Dr. Sarah Cannon, D.m.d, D.M.D
General Practice — Payments: $187,492
Dr. Glenda Crawford, Dmd, DMD
General Practice — Payments: $23,987
Dr. Norman Fine, Dmd, DMD
General Practice — Payments: $10,721
Dr. Luis Schlichting, D.d.s, M.s., Phd, D.D.S, M.S., PHD
General Practice — Payments: $9,107
Dr. Robert Hurley, D.d.s, D.D.S
General Practice — Payments: $7,787
Dr. Benjamin Daniel, Dmd, DMD
General Practice — Payments: $7,318